Alembic Pharma's JV Aleor Dermaceuticals gets American regulator nod for Testosterone Gel

Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its ANDA for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62%, Alembic Pharmaceuticals said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/386nyNq
via IFTTT